Company News & Events

Oryzon presentation at the B-debate 50 YEARS OF HISTONE ACETYLATION Barcelona Conference on Epigenetics and Cancer celebrated in CaixaForum, Barcelona.

2 October 2014

Tamara Maes talked on the use of Oryzon's Phase 1 inhibitor ORY-1001 in acute leukemia and on the use of the dual LSD1/MAOB inhibitor ORY-2001 for treatment of Alzheimer disease in this afternoon's Beyond Histone Acetylation session of the meeting. B-DEBATE seeks out answers to the challenges and needs of society in the field of life sciences.

Please, for more information do click on the following link.

Share this story